Related Experiment Videos
Modified time-kill assay against multidrug-resistant Enterococcus faecium with novel antimicrobial combinations.
C R Messick1, K A Rodvold, S L Pendland
1Department of Veterans Affairs, Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Center Avenue SE, Albuquerque, NM 87106-4180, USA.
The Journal of Antimicrobial Chemotherapy
|December 11, 1999
Summary
This study found no bactericidal or synergistic activity when testing chloramphenicol and quinopristin/dalfopristin with other antibiotics against multidrug-resistant Enterococcus faecium using a modified time-kill assay.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Multidrug-resistant Enterococcus faecium poses a significant threat.
- Limited effective treatment options exist for these infections.
- Evaluating antibiotic combinations is crucial for treatment strategies.
Purpose of the Study:
- To compare the in-vitro activity of chloramphenicol and quinopristin/dalfopristin in combination with vancomycin, ampicillin, or gentamicin against multidrug-resistant Enterococcus faecium.
- To assess the efficacy of a modified time-kill assay that simulates in-vivo conditions.
Main Methods:
- Utilized a modified time-kill assay with specific centrifugation and resuspension steps.
- Simulated steady-state serum concentrations of antibiotics.
- Tested combinations of chloramphenicol and quinopristin/dalfopristin with vancomycin, ampicillin, or gentamicin.
Main Results:
- None of the tested antibiotic agents, alone or in combination, demonstrated bactericidal activity.
- No synergistic effects were observed between the antibiotic combinations.
- The modified assay provided a closer simulation of in-vivo conditions.
Conclusions:
- The tested antibiotic combinations were not effective against multidrug-resistant Enterococcus faecium in this in-vitro model.
- The modified time-kill assay may offer a more relevant qualitative assessment of antimicrobial agent interactions.
- Further research is needed to identify effective treatment strategies for multidrug-resistant Enterococcus faecium infections.